Dual-Luciferase® Reporter Assay System

What is a dual-luciferase reporter assay?

A dual-luciferase reporter assay measures the activities of two luciferase enzymes—typically firefly and Renilla—from the same cell lysate. The firefly luciferase reporter reflects experimental gene regulation, while the Renilla luciferase serves as an internal control for normalization. This approach produces more accurate, reproducible results than single-reporter assays by correcting for variation in transfection efficiency, cell number, and lysis.

Why use Renilla luciferase as an internal control?

Renilla luciferase uses a different substrate (coelenterazine) than firefly luciferase (D-luciferin), so the two reactions do not interfere with each other and can be measured sequentially from the same sample. When driven by a weak constitutive promoter, Renilla expression is not expected to change with the experimental variable, making it an ideal reference normalizing for transfection efficiency and cell number across samples.

How do luciferin, ATP and O₂ generate measurable light in a firefly luciferase assay?

Firefly luciferase catalyzes the oxidation of its substrate D-luciferin in a two-step reaction. In the first step, ATP adenylates luciferin to form luciferyl-AMP. In the second step, molecular oxygen oxidizes luciferyl-AMP, producing oxyluciferin in an excited electronic state. When oxyluciferin relaxes to its ground state, it emits a photon of light. This light output is directly proportional to luciferase activity over a wide concentration range.

Does the DLR™ Assay require a special luminometer?

Yes. Because the DLR™ Assay uses a flash chemistry format, a luminometer with two reagent auto-injectors is required to ensure consistent timing between reagent addition and signal measurement. Promega maintains the DLReady™ program, which lists luminometers validated for use with the DLR™ Assay System. For injector-free workflows, consider the Dual-Glo® Luciferase Assay System (Cat.# E2920/E2940/E2980), which uses a stable glow chemistry with a ~2-hour signal half-life. The Dual-Glo® assay is compatible with any plate reader luminometer—no auto-injectors required—and is optimized for batch processing of 96- and 384-well plates.

What is the linear detection range of the DLR™ Assay?

The DLR™ Assay is linear over 7 orders of magnitude (7 logs) for both firefly and Renilla luciferase activities, with attomole (<10⁻¹⁸ mol) sensitivity when using a sensitive luminometer with a wide dynamic range like a GloMax® Discover. This wide dynamic range means that low signal changes can be detected, and highly active samples rarely require dilution before measurement.

When should I use a dual-luciferase assay versus a single-reporter assay?

Use the DLR™ Assay whenever transfection efficiency or cell viability varies across samples, which is typical in most cell-based reporter experiments. Normalization to Renilla eliminates this noise, making your data more reliable.

How can I reduce well-to-well variability in the DLR™ Assay?

The most effective strategies are: (1) normalize firefly to Renilla activity for every sample; (2) ensure consistent cell seeding density and transfection conditions; (3) use a multichannel pipette or liquid handler for lysis and reagent addition; (4) equilibrate all reagents to room temperature; and (5) use a DLReady™ luminometer with auto-injectors to eliminate manual timing variation.

Can the DLR™ Assay be used in cell-free systems?

Yes. The DLR™ Assay System is compatible with cell-free transcription/translation reactions (e.g., TNT® Coupled Reticulocyte Lysate Systems). This enables studying gene expression and regulation in a defined environment without the need for cell transfection—useful for synthetic biology, high-throughput screening and functional assays.

How does NanoLuc® compare to Renilla luciferase for use as an internal control?

NanoLuc® luciferase is up to 1,000-fold brighter than Renilla luciferase when expressed off the same promoter. The Nano-Glo® Dual-Luciferase Reporter Assay System (Cat.# N1610) uses NanoLuc® luciferase as one of the paired reporters. The NanoLuc® reporter is advantageous when reporter expression is very low, or when a brighter control signal is needed to maintain the normalization ratio within a useful dynamic range.

How do I optimize luciferase assay conditions for reproducible results?

Luciferase assay performance is sensitive to several preanalytical and analytical variables. Addressing these systematically is the most reliable path to low-variability, high-quality data.

Cell Density and Transfection

• Seed cells at consistent density 18–24 hours before transfection to ensure uniform confluency (~70–80% at time of transfection).
• Use the same transfection reagent lot and DNA:reagent ratio across all experiments. FuGENE® HD Transfection Reagent is validated for use with DLR™ Assay protocols.
• Always include a Renilla control vector (e.g., pRL-TK, pRL-CMV) at a fixed DNA ratio (typically 1:10 to 1:50 relative to the firefly construct) to enable normalization. Titrate this ratio to keep Renilla signal well within the linear range.

Lysis

• Use Passive Lysis Buffer (PLB) at 1X concentration; avoid freeze-thaw cycles after dilution.
• For adherent cells in 96-well plates, 20μl of 1X PLB per well is the standard volume. Increase volume proportionally for larger wells (e.g., 100μl for 24-well plates).
• Rock the plate at room temperature for 15 minutes to ensure complete lysis. Incomplete lysis is a common source of high variability.
• Freeze lysates at −70°C if not reading immediately; the DLR™ Assay is compatible with frozen lysates.

Measurement Conditions

• Use a DLReady™-validated luminometer with dual auto-injectors. The assay is optimized for 10 to 100μl injection volumes with 2-second delay and 10-second read integration time.
• Allow reagents to equilibrate to room temperature before use. Cold LAR II reagent reduces signal intensity.
• Both LAR II and Stop & Glo® Reagent should be prepared fresh or thawed just before use; avoid repeated freeze-thaw of mixed reagents.
• Read firefly luciferase within 5 minutes of LAR II addition and Renilla luciferase within 30 seconds of Stop & Glo® addition for consistent timing across all wells.

Data Normalization and Linear Range

• Calculate normalized reporter activity as: Firefly RLU ÷ Renilla RLU for each sample. Express results as fold-change relative to a negative control (empty vector or vehicle-treated cells).
• If firefly luciferase signals exceed the linear range of your luminometer (typically ≥10⁶ RLU), dilute lysates 1:10 in 1X PLB and re-measure. The 7-log linear range of the DLR™ Assay means dilution is rarely necessary under standard expression conditions.
• Confirm that Renilla control signals are within the linear range. Overexpression of the Renilla control (caused by excessive pRL vector DNA) can compress the dynamic range of normalization.
• Include a no-DNA transfection control (mock) to establish assay background, and a positive control construct of known activity to verify lot-to-lot consistency.

What can the dual-luciferase reporter assay be used to study?

The DLR™ Assay System is among the most cited reporter gene tools in the life sciences literature. Its combination of sensitivity, linearity and built-in normalization makes it suitable across a broad range of gene regulation research areas:

• Promoter and enhancer activity: Clone a putative regulatory element upstream of the firefly luciferase reporter to quantify its transcriptional activity in response to stimuli, mutations or co-expressed transcription factors.
• Signaling pathway activation: Use pathway-responsive promoter elements (e.g., CRE, NF-κB, AP-1, Wnt/TCF) upstream of firefly luciferase to screen compounds or genetic perturbations that activate or inhibit specific signaling cascades.
• Transcription factor binding and activity: Measure the transactivation potential of transcription factor constructs by co-transfection with reporter vectors containing their cognate binding sites.
• 3′ UTR regulation and miRNA activity: Insert 3′ UTR sequences downstream of the firefly luciferase coding sequence to study post-transcriptional regulation by miRNAs, RNA-binding proteins or other UTR elements.
• siRNA and shRNA validation: Confirm knockdown efficiency of RNA interference constructs by measuring loss of reporter activity driven by the target gene’s promoter or fused to its 3′ UTR.
• Viral promoter and replication studies: Monitor viral gene expression or replication activity using viral LTRs or promoters cloned upstream of firefly luciferase, normalized with a co-transfected Renilla construct.
• Cell-free transcription/translation: The DLR™ Assay is compatible with in vitro transcription/translation reactions, enabling gene expression and regulation studies in a defined environment without the need for cell transfection.